Respiratory Syncytial Virus study: Peginterferon α-2b injection
Official title Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia
ClinicalTrials.gov ID: NCT06881056
What this study is testing
What is Peginterferon α-2b injection?
This is an investigational medicine being studied as a potential treatment for respiratory syncytial virus (RSV) pneumonia in children. It is designed to help the body's immune system fight off the virus.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study checks if a specific medicine works well and is safe for treating RSV pneumonia in children.
- Who it's for
- The study is looking for children who have been diagnosed with RSV pneumonia.
- What's involved
- Participants will breathe in the medicine as a mist. They will be randomly placed in one of three groups to compare different treatments.
- Time commitment
- The study includes a screening phase, a treatment phase, and a follow-up period, but the exact duration is not specified.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 3
You may be able to join if
- (1)Age: 1 year ≤ age ≤ 3 years; (2) Gender: Both male and female participants are eligible
You likely can't join if
- (1) Presence of any of the following clinical symptoms before enrollment: a.
The study team makes the final eligibility decision.
Where it is enrolling
- Chengdu, Sichuan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 3 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chengdu, Sichuan, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.